Yu Liu

Model Development for the Real-World Emission Factor Measurement of On-Road Vehicles Under Heterogeneous Traffic Conditions: An Empirical Analysis in Shanghai

Yu Liu, Wenwen Jiang, Xiaoqiang Zhang, Tsehaye Adamu Andualem et autres

Global warming is attributed to anthropogenic emissions of CO2 and the contribution from the transport sector is significant. Estimating on-road vehicle CO2 emission factors is essential for guiding carbon-reduction efforts in transportation. In order to accurately calculate carbon emission factors from vehicles, …

cn (code pays fourni par la source)

Ezetimibe protects against alpha-amanitin-induced hepatotoxicity by targeting the NTCP receptor: Mechanistic insights from in vitro and in vivo models

Jinfang Xue, Xiran Lou, Deyuan Ning, Yan Yang et autres

cn (code pays fourni par la source)

Anti-HER2 biparatopic antibody KJ015 has near-native structure, functional balanced high affinity, and synergistic efficacy with anti-PD-1 treatment in vivo

Zheng Wang, Yu Liu, Yunxia Xu, Linlin Lu et autres

Currently approved human epidermal growth factor receptor 2 (HER2)-targeted antibody therapies are largely derived from trastuzumab, including trastuzumab-chemotherapy combinations, fixed-dose trastuzumab-pertuzumab combinations, and trastuzumab antibody-drug conjugates. To expand the options, bispecific antibodies, which may better utilize the benefits of combination therapy, are …

cn (code pays fourni par la source)